MILLER AINE (SVP, DEV & HEAD OF IRE OFFICE) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/22/2024ACC: 0001415889-24-022088
Officer· SVP, DEV & HEAD OF IRE OFFICE
Since Feb 2026
-5.20K
Net shares
Net seller
$42.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.20K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−5.20K
Price / share
$8.22
Trade value
$42.75K
% of position
3.1%
8/20/2024
165.83K→160.63K
Total
Net shares
−5.20K
Net value
-$42.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2024 | F · Tax Withholding | −5.20K | $8.22 | $42.75K | 3.1% | 165.83K | 160.63K |
| Total | −5.20K | -$42.75K | ||||||
Derivative Transactions0
No derivative transactions reported